Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “MRD”

403 trials

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 403 results

Not applicableLooking for participantsNCT06697483
What this trial is testing

Risk Stratification and MRD-driven Maintenance for MM After ASCT

Who this might be right for
Multiple Myeloma
Peking University People's Hospital 100
Not applicableNot Yet RecruitingNCT07254156
What this trial is testing

Tumor-Agnostic MRD Detection in Stage III Colorectal Cancer

Who this might be right for
Colorectal CancerMRDctDNA
Sun Yat-sen University 229
Large-scale testing (Phase 3)Study completedNCT04642469
What this trial is testing

Phase III Study to Determine Efficacy of Durvalumab in Stage II-III Non-small Cell Lung Cancer (NSCLC) After Curative Intent Therapy.

Who this might be right for
Carcinoma, Non- Small Cell Lung
AstraZeneca 30
Testing effectiveness (Phase 2)Looking for participantsNCT05536505
What this trial is testing

Adjuvant Treatment Based on MRD for EGFR Mutant NSCLC

Who this might be right for
MRD
Guangdong Association of Clinical Trials 180
Not applicableUnknownNCT06182917
What this trial is testing

Prognostic Value of MRD Detection in CA125 Non-sensitive Ovarian Cancer Patients

Who this might be right for
Ovarian Cancer
West China Second University Hospital 35
Not applicableNot Yet RecruitingNCT07689812
What this trial is testing

Randomized Open-Label Trial Evaluating ctDNA-Guided Interruption Versus Standard of Care Immune-Checkpoint Inhibitor (ICI) Therapy In Patients With Advanced / Metastatic Solid Tumors.

Who this might be right for
NSCLC (Advanced Non-small Cell Lung Cancer)NSCLC (Non-small Cell Lung Cancer)NSCLC (Non-small Cell Lung Carcinoma)+12 more
Natera, Inc. 920
Testing effectiveness (Phase 2)WithdrawnNCT06903702
What this trial is testing

Azacitidine and Venetoclax Versus a Stem Cell Transplant in People 65 Years and Older With Acute Myeloid Leukemia

Who this might be right for
Acute Myeloid Leukemia
Memorial Sloan Kettering Cancer Center
Not applicableStudy completedNCT01078337
What this trial is testing

T-cell Minimal Residual Disease (MRD) Evaluation Using Flow Cytometric Analysis

Who this might be right for
Leukemia, Lymphocytic, Acute
Stanford University 15
Early research (Phase 1)Active Not RecruitingNCT06358430
What this trial is testing

Dose Escalation and Expansion Study of TROP2 CAR Engineered IL-15- Transduced Cord Blood-derived NK Cells in Combination With Cetuximab in Patient With Colorectal Cancer (CRC) With Minimal Residual Disease (MRD)

Who this might be right for
Colorectal CancerMinimal Residual Disease
M.D. Anderson Cancer Center 10
Testing effectiveness (Phase 2)Looking for participantsNCT06426511
What this trial is testing

CtDNA-MRD Guided Consolidation Toripalimab in Stage IB-IIIA NSCLC

Who this might be right for
Lung Cancer, Nonsmall Cell
Sun Yat-sen University 80
Not applicableStudy completedNCT06525116
What this trial is testing

MRD Detection by NGS in Pediatric T-ALL

Who this might be right for
Acute Lymphoblastic Leukemia, Pediatric
The Children's Hospital of Zhejiang University School of Medicine 148
Not applicableLooking for participantsNCT05950087
What this trial is testing

Study on the Relationship Between Plasma MRD and cfDNA HPV and the Efficacy and Prognosis of Locally Advanced Cervical Cancer After Concurrent Chemoradiotherapy

Who this might be right for
Locally Advanced Cervical Cancer
Guizhou Provincial People's Hospital 30
Not applicableLooking for participantsNCT07214532
What this trial is testing

Signatera-Guided CDK4/6 Inhibitor Therapy in Breast Cancer

Who this might be right for
Breast NeoplasmsCarcinoma, Ductal, BreastReceptors, Estrogen (for ER-positive Requirement)
Natera, Inc. 725
Testing effectiveness (Phase 2)Study completedNCT00358072
What this trial is testing

Treatment of Adult ALL With an MRD-directed Programme.

Who this might be right for
Acute Lymphoblastic Leukemia
Northern Italy Leukemia Group 280
Not applicableUnknownNCT05603156
What this trial is testing

Olverembatinib Combined With Inotuzumab Ozogamicin in the Treatment ph+ ALL With MRD Persistent Positive

Who this might be right for
Ph+ ALLBone Marrow TransplantMinimal Residual Disease
Institute of Hematology & Blood Diseases Hospital, China 46
Not applicableLooking for participantsNCT05433753
What this trial is testing

Asian Multicenter Prospective Study in HER2 Positive Early Breast Cancer for Detecting MRD by ctDNA;HARMONY Study

Who this might be right for
HER2-positive Breast Cancer
National Cancer Center, Japan 60
Testing effectiveness (Phase 2)Looking for participantsNCT05940961
What this trial is testing

Inotuzumab Ozogamicin in the Treatment of MRD+ After HSCT of ALL

Who this might be right for
ALLMRD-positiveHematopoietic Stem Cell Transplantation
Sheng-Li Xue, MD 42
Not applicableActive Not RecruitingNCT05210283
What this trial is testing

CORRECT Study of Minimal Residual Disease Detection in Colorectal Cancer

Who this might be right for
Colorectal Cancer
Exact Sciences Corporation 1,017
Testing effectiveness (Phase 2)Looking for participantsNCT06284486
What this trial is testing

A Multi-Site Break Through Cancer Trial: Phase II Study Investigating Dual Inhibition of BCL2 and Menin in AML MRD Using the Combination of Venetoclax and Revumenib

Who this might be right for
Acute Myeloid Leukemia
M.D. Anderson Cancer Center 8
Not applicableUnknownNCT05795010
What this trial is testing

MRD Test in Common Risk Stage II Colorectal Cancer

Who this might be right for
Stage II Colorectal Cancer
First Affiliated Hospital Xi'an Jiaotong University 60
Next Page